Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Population pharmacokinetic analysis of linezolid in low body weight patients with renal dysfunction.

Tsuji Y, Yukawa E, Hiraki Y, Matsumoto K, Mizoguchi A, Morita K, Kamimura H, Karube Y, To H.

J Clin Pharmacol. 2013 Sep;53(9):967-73. doi: 10.1002/jcph.133.

PMID:
23918457
[PubMed - indexed for MEDLINE]
2.

Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin.

Hiraki Y, Tsuji Y, Matsumoto K, Morita K, Kamimura H, Karube Y.

Am J Med Sci. 2011 Dec;342(6):456-60. doi: 10.1097/MAJ.0b013e318218cf18.

PMID:
21681075
[PubMed - indexed for MEDLINE]
3.

Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient.

Tsuji Y, Hiraki Y, Matsumoto K, Mizoguchi A, Sadoh S, Kobayashi T, Sakamoto S, Morita K, Yukawa E, Kamimura H, Karube Y.

Scand J Infect Dis. 2012 Aug;44(8):626-9. doi: 10.3109/00365548.2011.652164. Epub 2012 Jan 21.

PMID:
22263918
[PubMed - indexed for MEDLINE]
4.

Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients.

Abe S, Chiba K, Cirincione B, Grasela TH, Ito K, Suwa T.

J Clin Pharmacol. 2009 Sep;49(9):1071-8. doi: 10.1177/0091270009337947. Epub 2009 Jun 23.

PMID:
19549796
[PubMed - indexed for MEDLINE]
5.

Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.

Stein GE, Schooley S, Peloquin CA, Missavage A, Havlichek DH.

J Antimicrob Chemother. 2007 Oct;60(4):819-23. Epub 2007 Aug 1.

PMID:
17673476
[PubMed - indexed for MEDLINE]
Free Article
6.

Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.

Sasaki T, Takane H, Ogawa K, Isagawa S, Hirota T, Higuchi S, Horii T, Otsubo K, Ieiri I.

Antimicrob Agents Chemother. 2011 May;55(5):1867-73. doi: 10.1128/AAC.01185-10. Epub 2011 Feb 28.

PMID:
21357301
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia model.

Lepak AJ, Marchillo K, Pichereau S, Craig WA, Andes DR.

Antimicrob Agents Chemother. 2012 Nov;56(11):5916-22. doi: 10.1128/AAC.01303-12. Epub 2012 Sep 10.

PMID:
22964254
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A reduced linezolid dosage maintains favorable efficacy with minimal hematologic toxicity in a methicillin-resistant Staphylococcus aureus-infected patient with renal insufficiency.

Taguchi K, Miyakawa T, Ohmura T, Horio M, Anraku Y, Okada T, Mizuta H, Saito H, Kawaguchi T.

Scand J Infect Dis. 2013 Jan;45(1):77-80. doi: 10.3109/00365548.2012.708783. Epub 2012 Sep 19.

PMID:
22992056
[PubMed - indexed for MEDLINE]
9.

Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction.

Tsuji Y, Hiraki Y, Matsumoto K, Mizoguchi A, Kobayashi T, Sadoh S, Morita K, Kamimura H, Karube Y.

J Infect Chemother. 2011 Feb;17(1):70-5. doi: 10.1007/s10156-010-0080-6. Epub 2010 Jun 26.

PMID:
20582446
[PubMed - indexed for MEDLINE]
10.

Serum and sputum concentrations following the oral administration of linezolid in adult patients with cystic fibrosis.

Saralaya D, Peckham DG, Hulme B, Tobin CM, Denton M, Conway S, Etherington C.

J Antimicrob Chemother. 2004 Feb;53(2):325-8. Epub 2004 Jan 16.

PMID:
14729733
[PubMed - indexed for MEDLINE]
Free Article
11.

Population pharmacokinetics of linezolid in patients treated in a compassionate-use program.

Meagher AK, Forrest A, Rayner CR, Birmingham MC, Schentag JJ.

Antimicrob Agents Chemother. 2003 Feb;47(2):548-53.

PMID:
12543657
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Pharmacokinetics of linezolid in subjects with renal dysfunction.

Brier ME, Stalker DJ, Aronoff GR, Batts DH, Ryan KK, O'Grady M, Hopkins NK, Jungbluth GL.

Antimicrob Agents Chemother. 2003 Sep;47(9):2775-80.

PMID:
12936973
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Plasma exposure of free linezolid and its ratio to minimum inhibitory concentration varies in critically ill patients.

Yagi T, Naito T, Doi M, Nagura O, Yamada T, Maekawa M, Sato S, Kawakami J.

Int J Antimicrob Agents. 2013 Oct;42(4):329-34. doi: 10.1016/j.ijantimicag.2013.06.015. Epub 2013 Aug 26.

PMID:
23988716
[PubMed - indexed for MEDLINE]
14.

Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure.

Tsuji Y, Hiraki Y, Mizoguchi A, Hayashi W, Kamohara R, Kamimura H, Karube Y.

J Infect Chemother. 2008 Apr;14(2):156-60. doi: 10.1007/s10156-008-0587-2. Epub 2008 Apr 30.

PMID:
18622681
[PubMed - indexed for MEDLINE]
15.

Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.

Stein GE, Schooley SL, Peloquin CA, Kak V, Havlichek DH, Citron DM, Tyrrell KL, Goldstein EJ.

Ann Pharmacother. 2005 Mar;39(3):427-32. Epub 2005 Feb 8.

PMID:
15701775
[PubMed - indexed for MEDLINE]
16.

Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.

Buerger C, Plock N, Dehghanyar P, Joukhadar C, Kloft C.

Antimicrob Agents Chemother. 2006 Jul;50(7):2455-63.

PMID:
16801426
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Oral bioavailability of linezolid before and after Roux-en-Y gastric bypass surgery: is dose modification necessary in obese subjects?

Hamilton R, Thai XC, Ameri D, Pai MP.

J Antimicrob Chemother. 2013 Mar;68(3):666-73. doi: 10.1093/jac/dks431. Epub 2012 Nov 15.

PMID:
23160755
[PubMed - indexed for MEDLINE]
Free Article
18.

In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.

Vidaillac C, Parra-Ruiz J, Winterfield P, Rybak MJ.

Int J Antimicrob Agents. 2011 Oct;38(4):301-6. doi: 10.1016/j.ijantimicag.2011.04.023. Epub 2011 Jul 20.

PMID:
21764263
[PubMed - indexed for MEDLINE]
19.

In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model.

Jacqueline C, Batard E, Perez L, Boutoille D, Hamel A, Caillon J, Kergueris MF, Potel G, Bugnon D.

Antimicrob Agents Chemother. 2002 Dec;46(12):3706-11.

PMID:
12435665
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Pharmacokinetics of linezolid in septic patients with and without extended dialysis.

Swoboda S, Ober MC, Lichtenstern C, Saleh S, Schwenger V, Sonntag HG, Haefeli WE, Hempel G, Hoppe-Tichy T, Weigand MA.

Eur J Clin Pharmacol. 2010 Mar;66(3):291-8. doi: 10.1007/s00228-009-0766-9. Epub 2009 Dec 16.

PMID:
20013257
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk